Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh.
about
Environmental Enteropathy: Elusive but Significant Subclinical Abnormalities in Developing Countries.The Multibiome: The Intestinal Ecosystem's Influence on Immune Homeostasis, Health, and DiseaseRotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review.Application of penalized linear regression methods to the selection of environmental enteropathy biomarkers.Secondary Carnitine Deficiency in Environmental Enteric Dysfunction.Entamoeba histolytica-Encoded Homolog of Macrophage Migration Inhibitory Factor Contributes to Mucosal Inflammation during Amebic Colitis.Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries.Dynamics and Trends in Fecal Biomarkers of Gut Function in Children from 1-24 Months in the MAL-ED Study.Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast BrazilPlasma Tryptophan and the Kynurenine-Tryptophan Ratio are Associated with the Acquisition of Statural Growth Deficits and Oral Vaccine Underperformance in Populations with Environmental Enteropathy.Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children.A Prospective Longitudinal Cohort to Investigate the Effects of Early Life Giardiasis on Growth and All Cause DiarrheaDelayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial.Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infantsCausal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort StudyBiomarkers of Environmental Enteric Dysfunction Among Children in Rural Bangladesh.Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics.Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children.Elevations in serum anti-flagellin and anti-LPS Igs are related to growth faltering in young Tanzanian children.Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs.Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents.Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.Interactions between intestinal pathogens, enteropathy and malnutrition in developing countriesEnvironmental enteropathy is associated with cardiometabolic risk factors in Peruvian children.Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island.Tropical Enteropathies.The Burden of Enteropathy and "Subclinical" Infections.Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a community-based intervention study to validate non-invasive biomarkers of environmental enteric dysfunction.Early Life Inflammation and Neurodevelopmental Outcome in Bangladeshi Infants Growing Up in Adversity.Biomarkers to Stratify Risk Groups among Children with Malnutrition in Resource-Limited Settings and to Monitor Response to Intervention.Diarrheal disease and enteric infections in LMIC communities: how big is the problem?Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.Rotavirus Vaccines: a story of success with challenges ahead.Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.Environmental Enteric Dysfunction: A Case Definition for Intervention Trials.Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors.Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.
P2860
Q26738740-1E9A0CC4-8758-4B2C-BE84-30B8F78F15C6Q28067461-DA9E08FC-E73E-4863-890E-1DAE163AFFFAQ30234306-56930551-EFD0-486F-BAD3-473136945711Q30252953-DEEF6989-54CC-4ECA-8076-D6630AEF6887Q30253056-DDABA53D-8C3D-482B-923B-C18085B85DF8Q30274801-165CB069-0D57-4034-8FB3-C6BC846F820AQ30274852-B5ABB642-0341-47F3-BB18-7F9E40330187Q30275186-9155789E-13D3-4C5E-BAD5-6DAE4880296EQ30275811-74F6B551-1BF7-49F1-B0EA-56344157FC00Q30276161-31208366-E726-40E7-83AD-AFDE036024F6Q30276480-602D0B7F-C755-4E5D-ACEF-796E7168CCB6Q30276563-83C6FDF9-152B-4FB5-A8E3-B389BE8C933BQ30276748-ACB4F555-B4A1-4B1D-B627-8A48D3B0E65EQ30276849-F5E3674E-17E5-4FDE-A4DD-8DDC50B31C25Q30352850-916FB4FC-5531-4532-9978-728B51989C74Q30491088-11AEBFED-9E71-40F2-94C7-E07C5598282BQ36060707-5BF3BC19-6868-42FA-A88E-B191681C317FQ36185607-7368425E-FA6B-498F-B406-7EAC74BFA57AQ36937657-BB42D109-F6D5-40B8-9C70-A083DBE110A1Q37400488-D6FAFB20-8234-4A22-B572-1B0A98CC45A7Q37563622-B6787799-A0A5-4BD4-A5F7-AC97570E146AQ38609819-2A93D962-C2B9-463C-9B1F-1097DF194DB6Q38612845-3B5A88D7-2870-4920-88EB-E6444EABE9EBQ38769846-2302FE96-7023-4619-AD3F-6BD7B2E44064Q38926344-93C8DCF6-0199-4273-8733-A1E9116851BDQ39018458-40040F5D-7B40-4CE8-9C64-96189FDFEFA2Q39190275-20F30B36-F9CA-4341-BCC0-77E62EC17FD1Q39451867-257B2D09-8C8C-4BB7-B2C3-430757DF753BQ40096556-4BB7A0D4-2559-479A-BD1E-3DE97AE16160Q40128420-C18F5E1D-2DD6-4178-B73A-7571EEA64372Q40209159-64F1422F-AA63-4734-919B-9299B41E9FF2Q40610987-31143B59-DFC6-4E04-94DF-5D65DE800507Q40693674-2E5DDBF6-E2FB-4C4F-B264-1CDCBEE4FB1FQ41589121-73AED05A-31ED-4FBA-A38C-E64D0AC3FCFFQ43365960-E5F85038-CF4A-4021-9C63-EDC07D8D978CQ45069663-5F5F6037-B743-40A1-BB47-4AEF79BAAC72Q46164556-13E33A20-9F31-43C0-BDC8-021B472B0B2EQ46243057-55D975F9-7F56-4652-BF47-B3F8DD23CD05Q47131363-33B305E3-2610-4B52-AE01-554648B313BEQ47291480-53CA6994-A375-4D65-B392-EECC832E7ACF
P2860
Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Environmental Enteropathy, Ora ...... ring in Infants in Bangladesh.
@ast
Environmental Enteropathy, Ora ...... ring in Infants in Bangladesh.
@en
type
label
Environmental Enteropathy, Ora ...... ring in Infants in Bangladesh.
@ast
Environmental Enteropathy, Ora ...... ring in Infants in Bangladesh.
@en
prefLabel
Environmental Enteropathy, Ora ...... ring in Infants in Bangladesh.
@ast
Environmental Enteropathy, Ora ...... ring in Infants in Bangladesh.
@en
P2093
P2860
P50
P1433
P1476
Environmental Enteropathy, Ora ...... ring in Infants in Bangladesh.
@en
P2093
Dorothy Dickson
Erica Buonomo
Fiona van der Klis
Josyf C Mychaleckyj
M Steven Oberste
Marya Carmolli
PROVIDE study teams
Ross Colgate
P2860
P304
P356
10.1016/J.EBIOM.2015.09.036
P50
P577
2015-09-25T00:00:00Z